Related references
Note: Only part of the references are listed.Clinical verification of sensitivity to preoperative chemotherapy in cases of androgen receptor-expressing positive breast cancer
Yuka Asano et al.
BRITISH JOURNAL OF CANCER (2016)
The Emerging Role of Neutrophil to Lymphocyte Ratio in Determining Colorectal Cancer Treatment Outcomes: A Systematic Review and Meta-Analysis
George Malietzis et al.
ANNALS OF SURGICAL ONCOLOGY (2014)
Elevated Serum Neutrophil to Lymphocyte and Platelet to Lymphocyte Ratios Could be Useful in Lung Cancer Diagnosis
Yasemin Kemal et al.
ASIAN PACIFIC JOURNAL OF CANCER PREVENTION (2014)
The preoperative lymphocyte to monocyte ratio predicts clinical outcome in patients with stage III colon cancer
M. Stotz et al.
BRITISH JOURNAL OF CANCER (2014)
The elevated preoperative platelet-to-lymphocyte ratio predicts poor prognosis in breast cancer patients
S. Krenn-Pilko et al.
BRITISH JOURNAL OF CANCER (2014)
Prognostic Role of Neutrophil-to-Lymphocyte Ratio in Solid Tumors: A Systematic Review and Meta-Analysis
Arnoud J. Templeton et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2014)
The Glasgow Prognostic Score Predicts Poor Survival in Cisplatin-Based Treated Patients with Metastatic Nasopharyngeal Carcinoma
Cui Chen et al.
PLOS ONE (2014)
Usefulness of Pretreatment Neutrophil to Lymphocyte Ratio in Predicting Disease-Specific Survival in Breast Cancer Patients
Hany Noh et al.
JOURNAL OF BREAST CANCER (2013)
Pretreatment neutrophil/lymphocyte ratio is superior to platelet/lymphocyte ratio as a predictor of long-term mortality in breast cancer patients
Basem Azab et al.
MEDICAL ONCOLOGY (2013)
Usefulness of the Neutrophil-to-Lymphocyte Ratio in Predicting Short- and Long-Term Mortality in Breast Cancer Patients
Basem Azab et al.
ANNALS OF SURGICAL ONCOLOGY (2012)
Platelet to lymphocyte ratio as a prognostic factor for epithelial ovarian cancer
Supachai Raungkaewmanee et al.
JOURNAL OF GYNECOLOGIC ONCOLOGY (2012)
Preoperative platelet lymphocyte ratio as an independent prognostic marker in ovarian cancer
Viren Asher et al.
CLINICAL & TRANSLATIONAL ONCOLOGY (2011)
The effect of peripheral blood values on prognosis of patients with locally advanced gastric cancer before treatment
Mehmet Aliustaoglu et al.
MEDICAL ONCOLOGY (2010)
Preoperative platelet-lymphocyte ratio is an independent significant prognostic marker in resected pancreatic ductal adenocarcinoma
Richard A. Smith et al.
AMERICAN JOURNAL OF SURGERY (2009)
New response evaluation criteria in solid tumours: Revised RECIST guideline (version 1.1)
E. A. Eisenhauer et al.
EUROPEAN JOURNAL OF CANCER (2009)
Comparison of the prognostic value of selected markers of the systemic inflammatory response in patients with colorectal cancer
E. F. Leitch et al.
BRITISH JOURNAL OF CANCER (2007)
Neoadjuvant therapy with paclitaxel followed by 5-fluorouracil, epirubicin, and cyclophosphamide chemotherapy and concurrent trastuzumab in human epidermal growth factor receptor 2-positive operable breast cancer: An update of the initial randomized study population and data of additional patients treated with the same regimen
Aman U. Buzdar et al.
CLINICAL CANCER RESEARCH (2007)
Clinical trial update: implications and management of residual disease after neoadjuvant therapy for breast cancer
Erica L. Mayer et al.
BREAST CANCER RESEARCH (2007)
Neoadjuvant versus adjuvant systemic treatment in breast cancer: A meta-analysis
D Mauri et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2005)
Classification of isolated tumor cells - Clarification of the 6th edition of the American Joint Committee on Cancer Staging Manual
SE Singletary et al.
CANCER (2003)
The effect on tumor response of adding sequential preoperative docetaxel to preoperative doxorubicin and cyclophosphamide: Preliminary results from national surgical adjuvant breast and bowel project protocol B-27
HD Bear et al.
JOURNAL OF CLINICAL ONCOLOGY (2003)
Improved outcomes from adding sequential paclitaxel but not from escalating doxorubicin dose in an adjuvant chemotherapy regimen for patients with node-positive primary breast cancer
IC Henderson et al.
JOURNAL OF CLINICAL ONCOLOGY (2003)
Preoperative chemotherapy in primary operable breast cancer: Results from the European Organization for Research and Treatment of Cancer trial 10902
JA van der Hage et al.
JOURNAL OF CLINICAL ONCOLOGY (2001)
Share Paper
